Overview
COVID-19 treatment refers to the medical strategies used to manage illness caused by SARS-CoV-2, the coronavirus responsible for the disease, ranging from supportive care for mild cases to intensive intervention for severe respiratory and systemic complications. Because the disease varies widely in severity, treatment is tailored to the clinical stage and may include supportive measures such as oxygen and fluid management, antiviral agents, immune-modulating therapies aimed at the inflammatory response, and management of complications such as pneumonia and abnormal blood clotting. Approaches evolved rapidly during the pandemic as evidence accumulated, and care also depends heavily on health-system capacity and resources. Research into COVID-19 treatment has examined candidate drugs, the timing and targeting of interventions, and the practical delivery of care across diverse settings. The journal publishes work relevant to these questions, including studies of cell-based therapy for the consequences of infection, viral kinetics under chloroquine-based regimens, the effect of hydroxychloroquine on clinical outcomes and mortality, the use of immune modulators such as interferon-gamma, changes in white-blood-cell and lymphocyte counts during early disease, the management of COVID-19-associated pneumonia, the impact of the pandemic on surgical practice, and multisectoral responses in limited-resource settings. Key aspects of study include supportive and pharmacological management, immunomodulation, risk stratification, and the adaptation of treatment to clinical severity and available resources.
Research published in this journal
12 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Cell Therapy as an Alternative approach for COVID-19 Infection Consequences: A Non-Systematic Review
SARS-Cov-2 Viral Kinetics in Mild COVID-19 Patients Treated with Chloroquine Regimens or Standard of Care
Effect of Hydroxychloroquine on Clinical Improvement and Mortality Among Patients with COVID-19 Admitted to Four General Hospitals in Saudi Arabia
The Dynamic Changes of White Blood Cell Count and Lymphocyte Count and Compare their Levels in the Early Stage of Covid-19
Features of the Emergence and Re-Emergence of Infectious Diseases, Geopolitics and Gain-of-Function Research
Use of Immune Modulator Interferon-Gamma to Support Combating COVID-19 Pandemic
COVID-19 and New Forms of Acute Pneumonia. It's Time for A Brainstorming Session
COVID-19 Pandemic: The Causative Agent is New, The Problem is Old
The Effect of Covid-19 Pandemic on Surgical Practice in Nigeria
Stratified Analysis of Factors Associated With Mortality in Patients With COVID-19 Based on Cancer and Diabetes
The Multi Sectorial Approach to COVID-19 Pandemic in Limited-Resource Settings: Discussing Rwandan Experience
How this research is being cited
The 12 articles above have been cited 16 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2025 · Inflammopharmacology
-
2025 · Inflammopharmacology
-
2023 · Frontiers in Medicine
-
2023 · Frontiers in Medicine
-
2022 · International Journal of Clinical Virology
-
2022 · International Journal of Clinical Virology
-
2021 · Open Access Journal of Pulmonary & Respiratory Sciences
-
2021 · International Journal of Clinical Practice
A sample of recent works citing this journal's research on Covid-19 Treatment, linking to each citing work.